IMV

About:

IMV is a clinical-stage immuno-oncology company.

Twitter/X: imv_inc

Top Investors: Fonds de solidarité FTQ, Lumira Ventures

Description:

IMV is a clinical-stage immuno-oncology company that wants to transform the way they engage human immunity to address some of the most complex, devastating diseases in today’s medical landscape.

Total Funding Amount:

$88.6M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Dartmouth, Nova Scotia, Canada

Founded Date:

2000-01-01

Founders:

Robert Brown

Number of Employees:

51-100

Last Funding Date:

2022-12-16

IPO Status:

Public

Industries: